ATE191919T1 - Hemmung von traumainduziertem tumorwachstum - Google Patents

Hemmung von traumainduziertem tumorwachstum

Info

Publication number
ATE191919T1
ATE191919T1 AT94908743T AT94908743T ATE191919T1 AT E191919 T1 ATE191919 T1 AT E191919T1 AT 94908743 T AT94908743 T AT 94908743T AT 94908743 T AT94908743 T AT 94908743T AT E191919 T1 ATE191919 T1 AT E191919T1
Authority
AT
Austria
Prior art keywords
trauma
inhibition
tumor growth
induced tumor
mammal
Prior art date
Application number
AT94908743T
Other languages
English (en)
Inventor
Arthur E Bodgen
Jacques-Pierre Moreau
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Application granted granted Critical
Publication of ATE191919T1 publication Critical patent/ATE191919T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT94908743T 1993-02-11 1994-02-08 Hemmung von traumainduziertem tumorwachstum ATE191919T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/016,720 US5504069A (en) 1993-02-11 1993-02-11 Inhibition of trauma-induced tumor growth
PCT/US1994/001412 WO1994018231A1 (en) 1993-02-11 1994-02-08 Inhibition of trauma-induced tumor growth

Publications (1)

Publication Number Publication Date
ATE191919T1 true ATE191919T1 (de) 2000-05-15

Family

ID=21778603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94908743T ATE191919T1 (de) 1993-02-11 1994-02-08 Hemmung von traumainduziertem tumorwachstum

Country Status (12)

Country Link
US (1) US5504069A (de)
EP (1) EP0644893B1 (de)
AT (1) ATE191919T1 (de)
AU (1) AU6172294A (de)
CA (1) CA2133557A1 (de)
DE (1) DE69424008T2 (de)
DK (1) DK0644893T3 (de)
ES (1) ES2144513T3 (de)
GR (1) GR3033968T3 (de)
PT (1) PT644893E (de)
WO (1) WO1994018231A1 (de)
ZA (1) ZA94960B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701952B1 (fr) * 1993-02-22 1995-03-31 Adir Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1999038011A1 (en) * 1998-01-21 1999-07-29 The Brigham And Women's Hospital, Inc. Circulating insulin-like growth factor-i and prostate cancer risk
AUPP221098A0 (en) * 1998-03-06 1998-04-02 Diatech Pty Ltd V-like domain binding molecules
US6150333A (en) * 1998-07-30 2000-11-21 Biomeasure, Inc. Methods of using a somatostatin analogue
IT1302289B1 (it) * 1998-09-30 2000-09-05 Univ Catania Composizioni farmaceutiche ad attivita' antineoplastica
CN1541102A (zh) * 2001-04-09 2004-10-27 生长激素抑制素激动剂

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4133782A (en) * 1976-06-07 1979-01-09 The Salk Institute For Biological Studies Somatostatin analogs with dissociated biological activities
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4316890A (en) * 1979-03-16 1982-02-23 Ciba-Geigy Corporation Peptides and processes for the manufacture thereof
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
CY1327A (en) * 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
US4358439A (en) * 1979-12-21 1982-11-09 Ciba-Geigy Corporation Cyclooctapeptides
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
EP0083305B1 (de) * 1981-12-24 1985-07-10 Ciba-Geigy Ag Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
US4486415A (en) * 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
NO893088L (no) * 1988-08-18 1990-02-19 Syntex Inc Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
PT644893E (pt) 2000-07-31
CA2133557A1 (en) 1994-08-18
GR3033968T3 (en) 2000-11-30
US5504069A (en) 1996-04-02
EP0644893A4 (de) 1995-09-20
DE69424008T2 (de) 2000-09-28
EP0644893B1 (de) 2000-04-19
DK0644893T3 (da) 2000-07-17
ES2144513T3 (es) 2000-06-16
ZA94960B (en) 1994-08-23
AU6172294A (en) 1994-08-29
EP0644893A1 (de) 1995-03-29
WO1994018231A1 (en) 1994-08-18
DE69424008D1 (de) 2000-05-25

Similar Documents

Publication Publication Date Title
EP0342541A3 (de) Retrovirale Protease-Inhibitoren
MX9707192A (es) Compuestos triciclicos de carbamato, utiles para la inhibicion de la funcion de la proteina g y paratratamiento de enfermedades proliferativas.
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
BG102510A (en) Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
BG102259A (en) Compostions with controlled paroxetine release
ATE192649T1 (de) Stereochemische wortmanninderivate
NO20003018D0 (no) Triazinangiogenese-inhibitorer
AU635961B2 (en) Novel peptidase and isomerase inhibitors
EP0048159A3 (de) Carboxyalkyl-Peptide und Thioäther und Äther von Peptiden als antihypertensive Mittel
WO1999005096A3 (en) Urokinase inhibitors
AU7607991A (en) Method of inhibiting gastric acid secretion
EP0254461A3 (de) Bekämpfung von Pflanzennematoden mittels substituierten Hydrazone
CO5261493A1 (es) Procedimiento y compuestos para la inhibicion de la mrp1
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
ATE191919T1 (de) Hemmung von traumainduziertem tumorwachstum
DK321081A (da) Fremgangsmaade til forhindring af nedbrydning af forbindelser fledt af thieno-pyridiner
WO1996023771A3 (en) Platelet aggregation inhibitors
DE69625505D1 (de) Guanidino proteiase inhibitoren
EP0127124A3 (de) Verbindungen zur Behandlung von hohem Blutdruck
EA199900479A1 (ru) Стабилизированные фармацевтические композиции на основе хинупристина и дальфопристина и способ получения
ES8403889A1 (es) Un metodo para preparar un compuesto de 1,4-dihidropiridina.
EP0325059A3 (de) Polymerisation hemmende Zusammensetzung für vinylaromatische Verbindungen
DE602004020971D1 (de) Schlammbehandlung
EP0331105A3 (de) 1,2-Hydroxy-Phophonate und Derivate davon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee